Exelon (NASDAQ:EXC – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Sunday.
Other equities analysts have also issued research reports about the company. KeyCorp set a $39.00 price objective on Exelon in a research note on Friday, December 12th. UBS Group raised their target price on Exelon from $48.00 to $51.00 and gave the stock a “neutral” rating in a report on Friday. Jefferies Financial Group reduced their price target on Exelon from $57.00 to $55.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Royal Bank Of Canada started coverage on Exelon in a research report on Wednesday, January 7th. They issued a “sector perform” rating and a $51.00 price objective on the stock. Finally, JPMorgan Chase & Co. cut their target price on shares of Exelon from $50.00 to $47.00 and set a “neutral” rating for the company in a report on Friday, December 12th. Eight analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $50.14.
Get Our Latest Analysis on EXC
Exelon Trading Up 0.9%
Exelon (NASDAQ:EXC – Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.55 by $0.04. Exelon had a net margin of 11.41% and a return on equity of 9.97%. The business’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.64 earnings per share. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. Sell-side analysts anticipate that Exelon will post 2.64 EPS for the current year.
Hedge Funds Weigh In On Exelon
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Cambient Family Office LLC purchased a new stake in shares of Exelon during the fourth quarter worth about $249,000. T. Rowe Price Investment Management Inc. boosted its holdings in Exelon by 65.3% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 89,309 shares of the company’s stock worth $3,893,000 after buying an additional 35,274 shares during the last quarter. Compound Planning Inc. increased its stake in Exelon by 5.8% during the 4th quarter. Compound Planning Inc. now owns 10,782 shares of the company’s stock worth $470,000 after buying an additional 591 shares in the last quarter. Invesco Ltd. increased its stake in Exelon by 3.5% during the 4th quarter. Invesco Ltd. now owns 16,209,215 shares of the company’s stock worth $706,560,000 after buying an additional 549,907 shares in the last quarter. Finally, Birchwood Financial Partners Inc. acquired a new position in shares of Exelon during the fourth quarter valued at approximately $35,000. 80.92% of the stock is owned by hedge funds and other institutional investors.
About Exelon
Exelon Corporation (NASDAQ: EXC) is a Chicago-based energy company that operates primarily as a regulated electric and natural gas utility holding company. The company’s businesses focus on the delivery of electricity and related services to residential, commercial and industrial customers, as well as investments in grid modernization, customer energy solutions and demand-side programs. Exelon’s operations emphasize reliable service delivery, infrastructure maintenance and regulatory compliance across its utility footprint.
Formed in 2000 through the merger of Unicom and PECO Energy, Exelon historically combined generation and regulated utility businesses.
Read More
- Five stocks we like better than Exelon
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.
